What is ConsignMed?
ConsignMed operates as a specialized service provider catering to the pharmaceutical, medical device, and biotechnology sectors. The company distinguishes itself by offering comprehensive clinical research support and project management expertise, effectively acting as an extension of its clients' internal teams. By prioritizing active thought and instinctual connections, ConsignMed facilitates the seamless execution of complex medical projects, ensuring that manufacturers can maintain operational efficiency while adhering to rigorous industry standards. Their market position is defined by a commitment to quality and a reputation for being an essential partner in the life sciences supply chain.
How much funding has ConsignMed raised?
ConsignMed has raised a total of $1.3M across 2 funding rounds:
Debt
$350K
Debt
$945K
Debt (2020): $350K with participation from PPP
Debt (2021): $945K led by PPP
Key Investors in ConsignMed
PPP
Public-Private Partnership
What's next for ConsignMed?
With the recent infusion of capital, ConsignMed is strategically positioned to expand its service footprint and enhance its technological capabilities in project management. The company is expected to focus on deepening its integration within the clinical research ecosystem, potentially scaling its field support teams to meet the rising global demand for specialized medical talent. By maintaining its focus on relationship-centric service delivery, ConsignMed aims to capitalize on the ongoing shift toward outsourced operational excellence in the healthcare sector. Future initiatives will likely involve optimizing internal processes to further drive efficiency for its diverse portfolio of pharmaceutical and biotech clients.
See full ConsignMed company page